Senores Pharmaceuticals Ltd Financials

Senores Pharmaceuticals Ltd Financial Statement

Senores Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Senores Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	34.01	10.40	13.54
Operating Expenses Annual	34.07	12.18	12.39
Operating Profit Annual	6.79	5.33	2.10
Interest Annual	2.71	2.00	0.56
Depreciation	1.48	0.19	0.14
Net Profit Annual	0.81	1.83	0.68
Tax Annual	1.22	0.75	0.15

Particulars	Mar 2024
Total Revenue Annual	34.01
Operating Expenses Annual	34.07
Operating Profit Annual	6.79
Interest Annual	2.71
Depreciation	1.48
Net Profit Annual	0.81
Tax Annual	1.22

Senores Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.09	1.41	1.64
Cash Flow from Operations	-62.82	-47.78	-24.06
Cash Flow from Investing	-13.51	1.07	-10.05
Cash Flow from Financing	86.68	45.33	33.88
Cash Flow at the End	10.44	0.03	1.41

Particulars	Mar 2024
Cash Flow at the Beginning	0.09
Cash Flow from Operations	-62.82
Cash Flow from Investing	-13.51
Cash Flow from Financing	86.68
Cash Flow at the End	10.44

Senores Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	19.94	40.47	15.51
PBIT Margin (%)	13.94	32.96	10.27
PBT Margin (%)	8.79	17.53	-8.05
Net PROFIT Margin (%)	2.38	9.69	5.02
Return On Networth / Equity (%)	0.78	3.30	3.15
Return On Networth /Employed (%)	2.56	5.44	4.51
Return On Assets (%)	0.43	1.65	2.21
Total Debt / Equity (X)	0.76	1.06	0.43
Asset Turnover Ratio (%)	0.18	0.17	0.44

Particulars	Mar 2024
PBDIT Margin (%)	19.94
PBIT Margin (%)	13.94
PBT Margin (%)	8.79
Net PROFIT Margin (%)	2.38
Return On Networth / Equity (%)	0.78
Return On Networth /Employed (%)	2.56
Return On Assets (%)	0.43
Total Debt / Equity (X)	0.76
Asset Turnover Ratio (%)	0.18

Senores Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	27.68	4.36	4.76
Total Current Assets Annual	39.96	19.30	13.98
Non Current Assets Annual	245.90	83.33	41.19
Total Shareholders Funds Annual	168.12	38.19	33.69
Total Assets Annual	285.86	102.63	55.17

Particulars	Mar 2024
Fixed Assets Annual	27.68
Total Current Assets Annual	39.96
Non Current Assets Annual	245.90
Total Shareholders Funds Annual	168.12
Total Assets Annual	285.86

Senores Pharmaceuticals Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Jan 4, 2025, Senores Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

No, Senores Pharmaceuticals Ltd is not debt-free with a debt-to-equity ratio of 0.60.

In FY 2024 , Senores Pharmaceuticals Ltd recorded a total revenue of approximately 34.01 Cr marking a significant milestone in the company's financial performance.

Senores Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.4% annually, respectively..

Senores Pharmaceuticals Ltd's current PE ratio is undefined.

Senores Pharmaceuticals Ltd's ROCE averaged 2.9% from the FY ending March 2022 to 2024, with a median of 2.9%. It peaked at 4.0% in March 2023, reflecting strong capital efficiency over the period..

Senores Pharmaceuticals Ltd's latest EBIT is Rs. 4.75 Cr, surpassing the average EBIT of Rs. 3.41 Cr over the 5 years..